Driven by a mission to empower a healthier world, we go beyond genetic testing to improve population health, reduce costs, and simplify decision-making. Explore a few of the many benefits realized by our partners and investors through our approach to precision medicine with genetics:

• Improvements in both patient health and employer bottom line
• Decreased costs of member care and insurance
• Alleviated privacy and confidentiality concerns
• Improved savings and performance benchmarks
• New revenue streams

• Availability of industry insights and trends
• Streamlined internal decision processes
• Improved prescribing accuracy
• Reduced member/patient absenteeism and increased productivity
• Greater returns on investment

 

We partner with leading members of the healthcare community to study the power of precision medicine genetics and personalized medicine data science, along with the impact it can have on participants. Partners include:

• American Society of Pharmacovigilance (STRIPE Collaborative Community)
• ARUP Laboratories
• Ascension SmartHealth
• The Chamber of Commerce for Greater Philadelphia
• Clinical Pharmacogenetics Implementation Consortium (CPIC)
• Dasa
• Employer Healthcare Innovation Roundtable (EHIR)
• Intermountain Healthcare
• KPMG

• National Council on Teacher Retirement (NCTR)
• Ovation
• Personalized Medicine Coalition (PMC)
• Pharmacogenomics Research Network (PGRN)
• Public Sector Healthcare Roundtable
• Quantigen
• Quest Diagnostics
• State and Local Government Benefits Association (SALGBA)
• The Teachers’ Retirement System of the State of Kentucky (TRS)
• ThermoFisher Scientific